Fas Gene Polymorphisms in Systemic Lupus Erythematosus and Serum Levels of Some Apoptosis-Related Molecules

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Immunological Investigations

• Publication date

  2010-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/08820130903401736PMID 20064083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden

  2006cited by this paper
• Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese

  2005influential reference
• Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.

  2005cited by this paper
• Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia

  2005cited by this paper
• Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia.

  2003cited by this paper
• Fas gene promoter polymorphisms in primary Sjögren’s syndrome

  2003cited by this paper
• Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians

  2002cited by this paper
• The FAS-670 polymorphism influences susceptibility to multiple sclerosis.

  2002cited by this paper
• A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.

  2002influential reference
• Complete mutation scan of the human Fas ligand gene: Linkage studies in Type I diabetes mellitus families

  2002cited by this paper
• Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.

  2001influential reference
• Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus

  2000cited by this paper
• Fas and Fas ligand gene polymorphisms in primary Sjögren's syndrome.

  2000cited by this paper
• INVESTIGATION OF THE -1377 POLYMORPHISM ON THE APO-1/FAS PROMOTER IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS USING ALLELE-SPECIFIC AMPLIFICATION

  2000cited by this paper
• Association of Fas/APO-1 gene polymorphism with systemic lupus erythematosus in Japanese.

  1999cited by this paper
• Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients.

  1999cited by this paper
• Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.

  1998cited by this paper
• Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

  1997cited by this paper
• Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias.

  1995cited by this paper
• Stat1 Depends on Transcriptional Synergy with Sp1 (*)

  1995cited by this paper
• Characterization of human Fas gene. Exon/intron organization and promoter region.

  1995cited by this paper
• Identification of a Silencer, Enhancer, and Basal Promoter Region in the Human CD95 (Fas/APO-1) Gene

  1995cited by this paper
• Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.

  1995cited by this paper
• Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

  1994cited by this paper
• Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

  1994cited by this paper
• Structure of the human APO‐1 gene

  1994cited by this paper
• Assignment of the human Fas antigen gene (Fas) to 10q24.1.

  1992cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper

• Genetic and molecular biology of systemic lupus erythematosus among Iranian patients: an overview

  2021cites this paper
• Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus

  2020cites this paper
• The BAFF/APRIL system: emerging new and unappreciated biomarkers in autoimmunity

  2019influential citation
• Association between FAS gene −670 A/G and −1377 G/A polymorphisms and the risk of autoimmune diseases: a meta-analysis

  2019cites this paper
• Tumor Cell Death via Apoptosis and Improvement of Activated Lymphocyte Cytokine Secretion by Extracts from Euphorbia Hebecarpa and Euphorbia Petiolata

  2019cites this paper
• FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barré syndrome

  2018cites this paper
• Anticancer potential of Ferula hezarlalehzarica Y. Ajani fraction in Raji lymphoma cell line: induction of apoptosis, cell cycle arrest, and changes in mitochondrial membrane potential

  2018cites this paper
• Tumor Necrosis Factor-Related Apoptosis Inducing Ligand in Systemic Lupus Erythematosus Patients : Potential Role in Disease Activity, Neutropenia and Renal Impairment

  2018cites this paper
• Apoptosis-inducing Effect of the Hexane Extracts from Three Native Iranian Euphorbia Plants

  2017cites this paper
• Associations between the FAS -670 A/G, -1377 G/A, and FASL -844 T/C polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis.

  2016cites this paper
• CLINICAL SIGNIFICANCE OF SOLUBLE SERUM FAS AND APO1/FAS GENE POLYMORPHISM (RS1800682) -670A>G IN SYSTEMIC LUPUS ERYTHEMATOSUS.

  2016cites this paper
• Role of CD134 and FAS and FAS Ligand Genes Polymorphism as Biomarkers for Disease Activity in Lupus Nephritis: A Preliminary Egyptian Study

  2016cites this paper
• APO-1/FAS Promoter (-670A/G) Polymorphisms and Risk of Lupus Nephritis in SLE Egyptian Female Patients

  2015cites this paper
• Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis

  2014cites this paper
• Fas Gene Variants in Childhood Acute Lymphoblastic Leukemia and Association with Prognosis

  2014cites this paper
• FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome.

  2014influential citation
• Up regulation of serum tumor necrosis factor‐related apoptosis inducing ligand in juvenile‐onset systemic lupus erythematosus: relations with disease activity, antibodies to double ‐stranded DNA, nephritis and neutropenia

  2013cites this paper
• Association of FAS and FAS Ligand Genes Polymorphism and Risk of Systemic Lupus Erythematosus

  2013cites this paper
• CTLA-4 -1722T/C Polymorphism and Systemic Lupus Erythematosus Susceptibility: A Meta-analysis Involving Ten Separate Studies

  2013cites this paper
• Association of Fas gene polymorphisms with systemic lupus erythematosus: a meta-analysis

  2012cites this paper
• Association of FAS gene polymorphisms with systemic lupus erythematosus: A case-control study and meta-analysis

  2012cites this paper
• Non-MHC genes linked to autoimmune disease.

  2012cites this paper
• The FAS/cd95 promoter single‐nucleotide polymorphism ‐670 A/G and lupus erythematosus

  2012cites this paper
• Association of PTPN22 C1858T Polymorphism and Type 1 Diabetes: A Meta-analysis

  2012cites this paper
• Genetics of lupus-untying the Gordian knot!

  2012cites this paper
• Antinuclear Antibodies Predicts a Poor IVF-ET Outcome: Impaired Egg and Embryo Development and Reduced Pregnancy Rate

  2012cites this paper
• Associations between the FAS −670 A/G and −1,377 G/A polymorphisms and susceptibility to autoimmune rheumatic diseases: a meta-analysis

  2012cites this paper
• Antinuclear antibodies are associated with tumor necrosis factor receptor I gene polymorphism in patients with rheumatoid arthritis.

  2011cites this paper